We are live on ! Find out more
KBC Group

KBC Group Portfolio holdings

AUM $39.9B
1-Year Est. Return 29.7%
This Fund
S&P 500
This Quarter Est. Return
+10.84%
1 Year Est. Return
+29.7%
3 Year Est. Return
+99.77%
5 Year Est. Return
+133.11%
10 Year Est. Return
+496.57%
AUM
$23.6B
AUM Growth
+$2.94B
Cap. Flow
+$1.39B
Cap. Flow %
5.9%
Top 10 Hldgs %
25.86%
Holding
1,550
New
35
Increased
606
Reduced
400
Closed
47

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$126M
2
MSFT icon
Microsoft
MSFT
+$121M
3
NVDA icon
NVIDIA
NVDA
+$90.9M
4
LIN icon
Linde
LIN
+$69.5M
5
UNH icon
UnitedHealth
UNH
+$61.4M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$63M
2
MRK icon
Merck
MRK
+$56.2M
3
TMO icon
Thermo Fisher Scientific
TMO
+$52.5M
4
ABBV icon
AbbVie
ABBV
+$49.3M
5
LLY icon
Eli Lilly
LLY
+$44.3M

Sector Composition

Rank Sector Weight
1 Technology 31.14%
2 Healthcare 18.83%
3 Financials 12.34%
4 Consumer Discretionary 9.93%
5 Consumer Staples 7.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HUM icon
76
Humana
HUM
$43.9B
$66.4M 0.28%
136,712
+20,560
+18% +$10.2M
AXP icon
77
American Express
AXP
$224B
$65.9M 0.28%
399,239
+12,416
+3% +$2.06M
MET icon
78
MetLife
MET
$62.4B
$65.6M 0.28%
1,132,392
-18,937
-2% -$1.28M
CL icon
79
Colgate-Palmolive
CL
$74.8B
$64.8M 0.28%
862,475
+66,277
+8% +$4.93M
XYL icon
80
Xylem
XYL
$28.5B
$63.1M 0.27%
603,082
+3,444
+0.6% +$360K
YUM icon
81
Yum! Brands
YUM
$41.9B
$62.8M 0.27%
475,375
+31,019
+7% +$3.99M
REGN icon
82
Regeneron Pharmaceuticals
REGN
$72.9B
$62.3M 0.26%
75,846
-33,233
-30% -$25.1M
ADI icon
83
Analog Devices
ADI
$172B
$61.6M 0.26%
312,499
+46,767
+18% +$8.38M
VRTX icon
84
Vertex Pharmaceuticals
VRTX
$123B
$60.5M 0.26%
192,078
-62,249
-24% -$18.7M
LOW icon
85
Lowe's Companies
LOW
$121B
$60.4M 0.26%
302,041
+64,347
+27% +$13.1M
ZTS icon
86
Zoetis
ZTS
$32.7B
$58.2M 0.25%
349,664
+37,383
+12% +$6.13M
PLD icon
87
Prologis
PLD
$136B
$57.4M 0.24%
459,921
+37,625
+9% +$4.62M
WM icon
88
Waste Management
WM
$95B
$56.9M 0.24%
348,895
+64,755
+23% +$9.92M
MU icon
89
Micron Technology
MU
$835B
$56.4M 0.24%
934,094
-96,102
-9% -$5.63M
LRCX icon
90
Lam Research
LRCX
$316B
$55.2M 0.23%
1,041,530
+373,670
+56% +$18.3M
MCO icon
91
Moody's
MCO
$83.7B
$55.2M 0.23%
180,232
-25,012
-12% -$7.56M
GS icon
92
Goldman Sachs
GS
$289B
$55.1M 0.23%
168,332
+63,634
+61% +$22.2M
COP icon
93
ConocoPhillips
COP
$144B
$54.9M 0.23%
553,571
-13,980
-2% -$1.53M
VMW
94
DELISTED
VMware, Inc
VMW
$54.3M 0.23%
434,771
-115,693
-21% -$13.9M
DXCM icon
95
DexCom
DXCM
$29B
$53.4M 0.23%
459,904
+63,247
+16% +$7.08M
BDX icon
96
Becton Dickinson
BDX
$46.4B
$53.1M 0.23%
214,404
+94,666
+79% +$23.2M
IDXX icon
97
Idexx Laboratories
IDXX
$44.9B
$52.8M 0.22%
105,543
+41,349
+64% +$19.8M
CB icon
98
Chubb
CB
$140B
$52.3M 0.22%
269,498
+12,756
+5% +$2.68M
DE icon
99
Deere & Co
DE
$165B
$52.3M 0.22%
126,692
-27,188
-18% -$11.3M
UPS icon
100
United Parcel Service
UPS
$88.9B
$50.9M 0.22%
262,371
+34,018
+15% +$6.24M

Similar funds

KBC Group's Q1 2023 Portfolio in Review

As of Q1 2023, KBC Group held 1,550 positions worth $23.6B, up 14% from $20.6B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

KBC Group deployed $1.39B of net new capital in Q1 2023, opening 35 new positions and adding to 606 existing holdings. Its largest new stake was GE HealthCare: 117,988 shares worth $9.68M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 27% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Apple, an estimated $63M trimmed.

  • KBC Group's largest Q1 2023 buy was GE HealthCare: 117,988 shares worth $9.68M.
  • KBC Group added most to Amazon in Q1 2023, an estimated $126M increase.
  • KBC Group's biggest Q1 2023 reduction was Apple, cutting an estimated $63M.
  • KBC Group fully exited Ingredion in Q1 2023, selling an estimated $4.04M.
  • KBC Group's ten largest holdings make up 26% of its $23.6B portfolio in Q1 2023.
  • KBC Group opened 35 new positions and closed 47 in Q1 2023.
  • KBC Group's portfolio value rose 14% quarter-over-quarter to $23.6B.

Based on KBC Group's 13F filing for Q1 2023, filed 4 May 2023.